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Abstract
Serine protease inhibitors (SERPINs) are involved in a variety of biological processes such as blood clotting, angiogenesis,
immune system, and embryogenesis. Although, of these, SERPINB12 is identified as the latest member of clade B in humans,
little is known of it in chickens. Thus, in this study, we investigated SERPINB12 expression profiles in various tissues of
chickens and focused on effects of steroid hormone regulation of its expression. In the chicken oviduct, SERPINB12 mRNA
and protein are abundant in the luminal (LE) and glandular (GE) epithelia of the magnum in response to endogenous or
exogenous estrogen. Furthermore, SERPINB12 mRNA and protein increase significantly in GE of cancerous ovaries of laying
hens with epithelia-derived ovarian cancer. Collectively, these results indicate that SERPINB12 is a novel estrogen-stimulated
gene that is up-regulated by estrogen in epithelial cells of the chicken oviduct and that it is a potential biomarker for early
detection of ovarian carcinomas in laying hens and women.
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Introduction
The chicken oviduct is well known as an excellent model for
basic mechanisms of organogenesis during developmental events.
In addition, the oviduct of laying hens consists of four anatomical
and functional components: the infundibulum is the site of
fertilization of the ovum; the magnum produces components of
egg-white; the isthmus for provides for formation of the shell
membrane in eggs; and the shell gland supports formation of the
egg shell [1,2]. Furthermore, the chicken oviduct is very suitable
for investigating morphological and physiological effects on
development and differentiation of reproductive tissues and organs
of vertebrates in response to sex steroid hormones [3]. Estrogen is
the primary sex steroid hormone that plays pivotal roles in cell
survival and proliferation, synthesis and secretion of egg white
proteins and formation and differentiation of tubular glands in the
developing oviduct of laying hens [4]. Results of our previous
studies indicate that estrogen-stimulated genes such as AHCYL1,
AvBD11, A2M, CTNNB1, ERBB1, PTN, SERPINB3, SERPINB11,
and SPP1 are involved in development of the chicken oviduct due
to their activation of various regulatory mechanisms that are
mediated via diverse trans-activating transcription factors and
complex actions of estrogen to effect physiological changes
[5,6,7,8,9,10,11,12,13]. Moreover, changes in circulating concen-
trations of estrogen following cessation and reinitiation of ovarian
steroidogenesis in response to induced molting regulates temporal
patterns of expression of these genes during remodeling and
development of the oviduct in laying hens [14]. However,
identification and characterization of additional genes to elucidate
mechanisms responsible for development of the chicken oviduct is
clearly warranted.
Serpins (serine protease inhibitors) are the largest family of
protease inhibitors present in blood and involved in various
proteolytic cascades including blood clotting and the complement
system in extracellular fluid and blood [15]. A subset of serpins
(clade B serpins) are called human ov-serpins because their
molecular structures are very similar to egg white proteins such as
ovalbumin [16]. Clade B serpins reside primarily within cells and
play important roles in various biological processes including
protection against certain apoptotic cascades, inhibition of cell
migration, and tumor suppression [17]. Of these, SERPINB12, also
known as yokopin, is located at 18q21.3 in the human genome
encoding a protein of 405 amino acids (about 46 kDa) and widely
expressed in various human tissues such as brain, heart, lung, liver,
spleen, pancreas, kidney, testes, ovary and placenta [18].
However, little is known about the expression and hormonal
regulation of SERPINB12 in chickens.
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Our research has discovered candidate genes and their
expression in the oviduct of immature chicks treated with
diethylstilbestrol (DES, a synthetic estrogen agonist) [19]. We
have also used DNA microarrays to identify estrogen regulated
genes critical to regulatory mechanisms for regression and
recrudescence of the oviduct of laying hens during induced
molting [14]. Our gene profiling data showed that SERPINB12
increased in the oviduct of chicks treated with DES, but not non-
treated chicks; therefore, it is likely to be regulated by changes in
secretion of estrogen from the ovary during regression and
recrudescence of the oviduct of laying hens during the molting
process. Therefore, we hypothesized that SERPINB12 has
essential roles in development and differentiation of the oviduct
in response to estrogen in laying hens. Hence, the aims of this
study were to: 1) determine gene expression patterns for
SERPINB12 in the immature chick oviduct treated with estrogen;
2) determine whether expression of SERPINB12 changes in the
oviduct of laying hens during regression, remodeling and
recrudescence phases following induced molting; and 3) compare
differential expression patterns for SERPINB12 in normal and
cancerous ovaries of laying hens.
Results
SERPINB12 mRNA expression in various organs from
chickens (Study one)
To determine tissue-specific patterns of expression of SER-
PINB12 mRNA in chickens, RT-PCR analyses were performed
using various organs including brain, heart, liver, kidney, muscle,
small intestine, gizzard, testis, ovary, and oviduct of 1- to 2- year-
old males (n = 3) and females (n = 3). As shown in Figure 1A and
1B, SERPINB12 gene is moderately expressed in all organs
irrespective of sex. However, there was high expression of
SERPINB12 mRNA in the oviduct of female chickens and in liver
and kidney from males. These results are very similar to a previous
report that SERPINB12 is detected in many adult and fetal tissues
of humans [18]. These results suggest that SERPINB12 plays an
important role(s) in various organs.
Estrogen regulates SERPINB12 expression in the
developing chicken oviduct (Study two)
To investigate the effects of estrogen on development of the
chick oviduct, we first performed quantitative PCR analysis using
each segment of the neonatal female chick oviduct treated with
DES: infundibulum, magnum, isthmus and shell gland. As
illustrated in Figure 2A, SERPINB12 mRNA increased 3.58-fold
(P,0.001) in the oviduct of DES-treated chick as compared to
non-treated chicks. SERPINB12 mRNA increased 2.44- (P,0.01),
5.17- (P,0.001), 3.22- (P,0.01) and 3.54-fold (P,0.001) in the
infundibulum, magnum, isthmus and shell gland segments of the
chick oviduct, respectively, in response to DES (Figure 2B). In
addition, in situ hybridization analysis revealed that SERPINB12
mRNA was expressed abundantly by luminal (LE) and glandular
(GE) epithelia of the magnum and moderately expressed by the
infundibulum, isthmus, and shell gland of oviducts from chicks
treated with DES (Figure 3A). Consistent with these results,
immunoreactive SERPINB12 protein was abundant in LE and
GE of the magnum and also expressed in other sections of the
oviduct at a low level (Figure 3B). However, the non-specific rabbit
IgG, used as a negative control, did not detect immunoreactive
SERPINB12 protein in the DES-treated chick oviduct.
Estrogen regulates SERPINB12 expression in the chicken
oviduct during the induced molting (Study three)
In this study, we evaluated the effects of estrogen on expression
of SERPINB12 during the regression and recrudescence phases of
molting in laying hens. As shown in Figure 4A, SERPINB12
expression decreased sharply between Days 6 and 12 of molting
(regression phase) and the increased 6.75-fold and 666.83-fold (P,
0.01,0.001) between Days 20 and 30, respectively, of the molting
process (recrudescence phase). In situ hybridization analysis
revealed that SERPINB12 mRNA is expressed in the LE and
GE on Day 0, but expression ceased as concentrations of estrogen
in blood decreased from Days 1 to 20 of the molting period
(Figure 5A and 5B). However, expression of SERPINB12 mRNA
increased with increasing concentrations of estrogen in blood
between Days 21 and 35 of the molting process. Likewise,
immunohistochemial analyses revealed that SERPINB12 protein
was predominantly localized to LE and GE of the oviduct during
the regeneration phase of the oviduct following induced molting.
Distinct expression pattern of SERPINB12 in normal and
cancerous ovaries of hens (Study four)
We previously reported that estrogen receptor alpha (ESR1) mRNA
expression increased about 51-fold (P,0.001) and immunoreactive
ESR1 protein was most abundant in GE of cancerous ovaries, but
not detectable in normal ovaries. Those results indicated that
estrogen-stimulated genes in the oviduct may also increase in
cancerous ovaries of hens in response to estrogen. Thus, we
examined whether SERPINB12 is expressed in cancerous ovaries
of laying hen in the present study. As illustrated in Figure 6A,
SERPINB12 mRNA expression increased 206.16-fold (P,0.01) in
cancerous as compared to normal ovaries of laying hens. To
compare cell-specific localization of SERPINB12 between normal
and cancerous ovaries, we performed in situ hybridization and
immunohistochemical analyses to find abundant expression of
SERPINB12 mRNA and protein specifically in GE of cancerous
ovaries, but not stromal cells or blood vessels of cancerous ovaries,
or in any cells of normal ovaries (Figures 6B and 6C). This result
indicates that SERPINB12 expression increases in cancerous
ovaries of laying hens as compared with normal ovaries, and that
its expression is co-localized to cells in cancerous ovaries
expressing ESR1.
Discussion
Results of the present study provide the first evidence of
SERPINB12 gene expression in the reproductive organs of female
chickens in response to estrogen. Additionally, the results are the
first to demonstrate that SERPINB12 expression is uniquely
expressed in cancerous ovaries, but not normal ovaries of laying
hens. Thus, results of the present study support our hypothesis that
SERPINB12 serves essential roles in development and differenti-
ation of the oviduct, as well as ovarian tumorigenesis in response to
estrogen in laying hens.
The serpin superfamily has 16 clades and over 500 members
with most involved in proteolytic activity in various biological
processes [20]. Of these, the clade B serpins, also known as
ovalbumin-related serpins (ov-serpins), are encoded for by 13
genes including monocyte neutrophil elastase inhibitor (SERPINB1),
plasminogen activator inhibitor-2 (SERPINB2), maspin (SERPINB5), and
plasminogen activator inhibitor-6 (SERPINB6) [21]. Because SER-
PINB12 is the latest known member of clade B, little is known
about it or its role in the chicken. In this study, we found that
chicken SERPINB12 is expressed moderately in various tissues
from both sexes as reported for humans [18]. Interestingly,
SERPINB12 in the Avian Oviduct and Ovary
PLOS ONE | www.plosone.org 2 July 2014 | Volume 9 | Issue 7 | e99792
SERPINB12 mRNA and protein are expressed abundantly in the
chicken oviduct, particularly in the LE and GE of the magnum.
However, it is also moderately expressed in the infundibulum,
isthmus, and shell gland of the chicken oviduct. These results
suggest that SERPINB12 plays an essential role in secretion or
storage of egg white proteins in the magnum of the chicken
oviduct.
Previous gene profiling data indicated that SERPINB12 might
be regulated by estrogen in the oviduct of laying hens fed a high
zinc diet to induce molting [14]. During molting, the oviduct and
ovary of laying hens undergo regression and remodeling and then
both undergo recrudescence in response to increases in circulating
concentrations of estrogen [22]. Our previous study showed that
concentrations of estradiol in serum decreased during the induced
molting period (Days 0 to 20) and then increased during the
recrudescence period (Days 20 to 35). This result suggested that
proliferation of oviductal cells between Days 25 and 30 of the
molting period is likely induced by estrogen following resumption
of ovarian steroidogenesis. Based on those results and our gene
profile data, we selected and examined SERPINB12 expression in
the current study, and we found it to increase significantly in
oviductal tissue during the remodeling and recrudescent phases
(Day 25 to Day 35) when concentrations of estrogen increase
during induced molting. These results indicate that SERPINB12 is
a novel gene likely involved in regulatory mechanisms(s) for
differentiation of the oviduct of neonatal chicks, as well as tissue
regeneration and remodeling of the oviduct of laying hens in
response to estrogen.
It is well know that DES implants and endogenous estrogen
induce development of the neonatal chick oviduct including
differentiation of oviductal tubular glands and ciliated cells, and
the synthesis and secretion of egg white proteins by epithelial cells
of the magnum [1,23]. Our previous studies showed that
SERPINB3 and SERPINB11 are also expressed in a cell-specific
manner in the chicken oviduct in response to estrogen [5,8].
Furthermore, using microarray analysis to examine transcript
changes in chick oviducts after exposure to DES, we reported that
SERPINB12 mRNA expression changed significantly during
oviduct development in chickens [19]. Therefore, we examined
expression of SERPINB12 in the oviduct of DES treated chicks in
Figure 1. Expression of SERPINB12 in various organs of both male and female chickens. Results of RT-PCR analysis using cDNA templates
from different organs of both male [A] and female [B] chickens with chicken SERPINB12 and chicken GAPDH-specific primers are shown. SERPINB12
gene was generally expressed in all organs from male and female chickens. Its expression was highly abundant in the chicken oviduct.
doi:10.1371/journal.pone.0099792.g001
Figure 2. Effect of DES on tissue specificity of expression of chicken SERPINB12 by quantitative PCR analyses. Quantitative PCR
analyses showed that SERPINB12 mRNA was more abundant in the oviducts of DES-treated chicks, as compared with oviducts from control chicks [A].
Among the four segments of oviducts from DES-treated chicks, SERPINB12 was most highly expressed in the magnum [B]. The asterisks denote
statistically significant differences (mean 6 SEM; ** P,0.01 or *** P,0.001).
doi:10.1371/journal.pone.0099792.g002
SERPINB12 in the Avian Oviduct and Ovary
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this study and found that expression of SERPINB12 mRNA and
protein is also regulated by estrogen in a tissue- and cell-specific
manner during development and differentiation of the chicken
oviduct. These results suggest that SERPINB12 may have effects
on the process of secretion or storage of egg white proteins.
Recently, Crum and colleagues reported that ovarian cancer
(pelvic serous cancer) may originate from the distal end of the
oviduct [24]. In fact, epithelial cell-derived ovarian cancer (EOC)
is one of the most lethal causes of cancer-related deaths among
women due to the fact that there are no or few symptoms and lack
of markers for its diagnosis in early stages of the disease [25].
Although several animal models for research to develop novel
biomarker for early detection of EOC and appropriate medical
treatment have been developed, most of them are not effective.
Interestingly, laying hens are being recognized as a good model
because chicken EOC occurs spontaneously, and tumor progres-
sion, and histological and pathological types and stages are very
similar to that in women [26,27]. Trevino and colleagues reported
that EOC may arise from the oviduct and about one-half of up-
regulated genes in EOC are oviduct-related genes in response to
estrogen stimulation in the laying hen model [28]. Indeed, we
reported on several estrogen-stimulated genes including CTSB,
SERPINB11, SERPINB3, AHCYL1, SPP1, A2M, PTN, AvBD-11,
CTNNB1 [6,7,9,12,29,30,31,32] and several cell cycle genes [33]
which are mainly expressed in the chicken oviduct and expressed
abundantly in GE of cancerous ovaries from laying hens.
Figure 3. Localization of SERPINB12 mRNA and protein in oviducts of DES-treated and non-treated chicks. [A] In situ hybridization
analyses indicated cell-specific expression of SERPINB12 mRNA in GE and LE of the four segments of oviducts from DES-treated chicks. However, there
was no expression of SERPINB12 in oviducts from control chicks. [B] Immunoreactive SERPINB12 protein was localized to LE and GE of oviducts of
chicks treated with DES, especially the magnum. For the IgG control, normal rabbit IgG was substituted for the primary antibody. Sections were not
counterstained. Legend: LE, luminal epithelium; GE, glandular epithelium; Scale bar represents 200 mm (the first columnar panels, sense and IgG) and
50 mm (the second columnar panels).
doi:10.1371/journal.pone.0099792.g003
Figure 4. Quantitation of SERPINB12 mRNA during regression and recrudescence of the magnum of laying hens during induced
molting. Quantitative PCR was conducted using cDNA templates from the magnum of hens fed a control diet (Day 0), zinc fed hens in which the
oviduct was regressing (Day 6 and 12) [A], and hens in which the oviduct was undergoing recrudescence (Day 20, 25, 30, and 35) [B]. These
experiments were performed in triplicate and normalized to control GAPDH expression. The asterisks denote statistically significant differences (mean
6 SEM; ** P,0.01 or *** P,0.001).
doi:10.1371/journal.pone.0099792.g004
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Similarly, we found that expression of SERPINB12 mRNA and
protein increase significantly in GE of in cancerous, but not
normal ovaries of laying hens. As a matter of fact, among clade B
serpins, SERPINB3 and SERPINB5 are well studied by various
cancer researchers. SERPINB3 was first discovered in squamous
cell carcinoma of the cervix [34] and it has been investigated in a
variety of squamous cell carcinoma types [35,36,37,38]. SER-
PINB3 is also involved in invasiveness of cells, as well as cell
migration, apoptosis, and immune reaction [39,40]. SERPINB5,
also known as maspin (mammary serine protease inhibitor) is a
class II tumor suppressor gene identified in patients with breast
cancer [41]. SERPINB5 promotes apoptotic events of invasive
prostate and breast carcinoma cells [41] and down-regulation of its
expression causes pancreatic, colorectal, and ovarian adenocarci-
nomas [42]. On the contrary, over-expression of SERPINB5 was
detected in two ovarian cancer cell lines including OVCAR3 and
SKOV3 whereas the normal ovarian surface epithelial cells do not
express SERPINB5 [43]. In our previous studies, we found
increased expression of SERPINB3 in chicken ovarian carcino-
genesis and suggested that it as a novel biomarker for predicting
platinum resistance and poor prognosis for survival in patients
with EOC [31]. In addition, SERPINB11 expression is dramat-
ically increased in laying hens with progressive endometrioid
adenocarcinoma of the ovary [30]. Furthermore, estrogen is a
well-known risk factor for gynecological cancer in women [44].
Our previous report showed that ESR1 mRNA expression is up-
regulated 51-fold (P,0.001) in ovarian cancer in laying hens while
there is little or no detectable ESR1 protein in normal ovaries [12].
Results of the present study indicate that expression of SERPINB12
mRNA increased about 206-fold (P,0.001) only in ovarian
carcinoma of laying hens. In addition, we observed that
SERPINB12 localized predominantly to GE of cancerous ovaries.
This glandular architecture is one of the most common
characteristics of ovarian cancer in laying hens and women and
it is estrogen-dependent and mainly appears in pre- and peri-
menopausal women [26,45]. Therefore, based on our current
results, SERPINB12 may play an important role(s) in the
development of EOC in laying hens, and be a potential biomarker
for early detection and monitoring of therapies used to treat EOC
in women.
Figure 5. Cell-specific localization of SERPINB12 mRNA and protein during regression and recrudescence of the magnum of
oviducts from hens during induced molting. The localization of SERPINB12 mRNA in the magnum of hens on different days of the regression
phase [A] and recrudescence phase [B] was analyzed by in situ hybridization. It was predominantly expressed in GE and LE of the magnum on Days 0,
25, 30 and 35 of the recrudescence phase of molting. On the other hand, the expression of SERPINB12 was rarely detected on Days 6, 12 and 20 of the
regression phase of dietary zinc induced molting. Immunoreactive SERPINB12 protein in the magnum during the regression phase [C] and
recrudescence phase [D] was analyzed by immunohistochemistry. Consistent with SERPINB12 mRNA localization, SEPRINB12 protein was mainly
detected in GE and LE of the magnum on Days 0, 25, 30 and 35 during the recrudescence phase of the oviduct during molting. Legend: LE, luminal
epithelium; GE, glandular epithelium; Scale bar represents 200 mm (the first horizontal panels, sense and IgG) and 50 mm (the second horizontal
panels).
doi:10.1371/journal.pone.0099792.g005
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Figure 6. Distribution and localization of SERPINB12 mRNA and protein in normal and cancerous ovaries from laying hens. [A]
Quantitative PCR was conducted using cDNA templates from normal and cancerous ovaries of hens. The expression of SERPINB12 was unique to
cancerous ovaries of laying hens as compared with normal ovaries from laying hens. [B] In situ hybridization analyses indicated cell-specific
localization of SERPINB12 mRNA in normal and cancerous ovaries from laying hens. SERPINB12 was strongly expressed in the GE of cancerous ovaries
whereas there was no expression in any cells of normal ovaries. [C] Immunoreactive SERPINB12 protein, as for SERPINB12 mRNA, was also unique to
the GE of cancerous ovaries from laying hens. Legend: F, follicle; GE, glandular epithelium. Scale bar represents 50 mm (the first columnar panels,
sense and IgG) and 200 mm (the second columnar panels).
doi:10.1371/journal.pone.0099792.g006
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Collectively, results of the current study demonstrate that
SERPINB12 is a novel estrogen-stimulated gene expressed
specifically in GE during development and differentiation of the
chicken oviduct. In addition, SERPINB12 is clearly associated
with and may be an essential regulatory factor in abnormal growth
and dysfunction of ovarian carcinomas. Therefore, our study
provides new insights into the use of SERPINB12 as an
ethiological and pathogenetical biomarker for chicken ovarian
carcinoma and its use as a biomarker for diagnosis and monitoring
of the effectiveness of therapies for treatment of EOC in women.
Materials and Methods
Experimental Animals and Animal Care
The experimental use of chickens for this study was approved by
the Animal Care and Use Committee of Korea University. All
chickens were exposed to a light regimen of 15 h light and 9 h
dark with ad libitum access to feed and water, and subjected to
standard poultry husbandry guidelines.
Tissue Samples
Study one. Following euthanasia of 1- to 2-year-old laying
White Leghorn (WL) hens, tissue samples were collected from
brain, heart, liver, kidney, small intestine, gizzard, muscle, ovary
and oviduct (n = 5). Subsets of these samples were frozen or fixed
in 4% paraformaldehyde for further analysis. Frozen tissue
samples were cut into 5- to 7-mm pieces, frozen in liquid nitrogen
vapor, and stored at 280uC. The other samples were cut into 10-
mm pieces and fixed in fresh 4% paraformaldehyde in PBS
(pH 7.4). After 24 h, fixed tissues were changed to 70% ethanol
for 24 h and then dehydrated and embedded in Paraplast-Plus
(Leica Microsystems, Wetzlar, Germany). Paraffin-embedded
tissues were sectioned at 5 mm.
Study two. Female chicks were identified by PCR analysis
using W chromosome-specific primer sets (F: 59-CTA TGC CTA
CCA CAT TCC TAT TTG C-39 and R: 59-AGC TGG ACT
TCA GAC CAT CTT CT-39). Treatment with DES and recovery
of the oviduct were conducted as reported previously [8]. We
implanted a 10 mg DES pellet in the abdominal region of 1-week-
old female chicks to release the hormone for 10 days. The DES
pellet was removed from all chicks for 10 days, and then a 10 mg
daily dose was administered for 10 additional days. Five chicks
were assigned to each treatment group. For control chicks, tissues
were collected from the middle part of the undifferentiated
neonatal oviduct. On the other hand, four segments including
infundibulum, magnum, isthmus, and shell gland were collected
from the differentiated oviduct of DES-treated neonatal chicks.
Study three. Molting of laying hens was induced by adding
20,000 ppm zinc to the diet to effectively reduce feed-intake and
induce molting [46,47]. Briefly, molting was induced by feeding
hens a diet containing high zinc (mixed 252 g zinc oxide per 10 kg
feed to achieve a final concentration of 20,000 ppm of zinc).
Laying hens in the molting group completely ceased egg
production within 12 days after feeding the high zinc-diet. The
35 laying hens (47-week-old) were divided into two groups; a
molting-progressing group and a post-molting-progressing group,
and kept in individual cages. The molting group was further
divided into three subgroups based on the number of days of
feeding the high zinc diet (normal feeding group, and 6 days and
12 days after onset of zinc feeding). The recrudescence (post-
molting) group was divided into four subgroups based on the
number of days from complete cessation of egg laying and
initiation of feeding a normal commercial diet: 20, 25, 30 or 35
days after onset of zinc feeding or 8, 13, 18 or 23 days on normal
feed after cessation of egg production and removal from the high
zinc diet.
Study Four. In this study, a total of 136 laying hens (88 over
36 months of age and 48 over 24 months of age) which had
stopped laying eggs were euthanized for collection of normal and
cancerous ovaries. From that population of laying hens, we
obtained cancerous ovarian tissue from 10 hens and normal
ovarian tissues from 10 egg-laying hens of similar age. We
evaluated tumor stage of 10 hens with cancerous ovaries according
to characteristic features of chicken ovarian cancer [26,30]. Three
hens had stage III disease as ovarian tumor cells had metastasized
to the gastrointestinal (GI) tract and liver surface with profuse
ascites in the abdominal cavity. Five hens had tumor cells spread
to distant organs including liver parenchyma, lung, GI tract and
oviduct with profuse ascites, indicating stage IV disease. Two hens
had stage I disease as tumors were limited to their ovaries.
Epithelial ovarian cancers in chickens were classified based on
their cellular subtypes and patterns of cellular differentiation with
reference to ovarian malignant tumor types in humans [26].
RNA Isolation
Total cellular RNA was isolated from frozen tissues (100 mg)
using Trizol reagent (Invitrogen, Carlsbad, CA) according to the
manufacturer’s recommendations. First, the tissues were homog-
enized with 1 ml Trizol using a power homogenizer and 0.2 ml of
chloroform was added to homogenized samples. Then, the tubes
were shaken vigorously by hand for a few seconds. The samples
were incubated at room temperature for 3 min and centrifugated
at 12,0006g for 15 min at 4uC. The aqueous phase of the sample
was placed in a new 1.5 ml tube and 0.5 ml of isopropanol was
added. After incubating the mixture for 10 min at room
temperature, the samples were centrifuged at 12,0006g for
10 min at 4uC. The resulting RNA pellet was washed using
75% ethanol and dried in air. Finally, the pellet was resuspended
in RNase-free water.?The quantity and quality of total RNA was
determined by spectrometry and denaturing agarose gel electro-
phoresis, respectively. The quantity and purity of RNA were
measured using a Nanodrop 2000 (Thermo Scientific, DE, USA).
We confirmed RNA purity in samples with a 260/280 nm ratio
greater than 1.8.
Semiquantitative RT-PCR analysis
The cDNA was synthesized from total cellular RNA (2 mg) using
random hexamer (Invitrogen, Carlsbad, CA) and oligo (dT)
primers and AccuPower RT PreMix (Bioneer, Daejeon, Korea).
The cDNA was diluted (1:10) in sterile water before use in PCR.
For SERPINB12, the forward primer (59-TCT TAA CCA CGA
AGC GTT CC-39) and reverse primer (59-AAC TTG TGT TCC
CAG GAT GC-39) amplified a 333-bp product. For GAPDH
(housekeeping gene), the forward primer (59-CAC AGC CAC
ACA GAA GAC GG-39) and reverse primer (59-CCA TCA AGT
CCA CAA CAC GG-39) amplified a 443-bp product. The
procedures for generation of primers, PCR amplification and
verification of their sequences were as described previously
[48,49]. PCR amplification was conducted using approximately
120 ng cDNA as follows: (1) 95uC for 3 min; (2) 95uC for 20 sec,
60uC for 40 sec and 72uC for 1 min for 35 cycles for SERPINB12
and 32 cycles for GAPDH; and (3) 72uC for 10 min. After PCR,
equal amounts of reaction product were analyzed using a 1%
agarose gel, and PCR products were visualized using ethidium
bromide staining. The amount of DNA present was quantified by
measuring the intensity of light emitted from correctly sized bands
under ultraviolet light using a Gel Doc XR+system with Image
Lab software (Bio-Rad).
SERPINB12 in the Avian Oviduct and Ovary
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Quantitative RT-PCR Analysis
Total RNA was extracted from each tissue sample using Trizol
(Invitrogen) and purified using an RNeasy Mini Kit (Qiagen).
Complementary DNA was synthesized using a Superscript III
First-Strand Synthesis System (Invitrogen). Gene expression levels
were determined using SYBR Green (Biotium, Hayward, CA,
USA) and a StepOnePlus Real-Time PCR System (Applied
Biosystems, Foster City, CA, USA). The GAPDH gene was
analyzed simultaneously as a control and used for normalization to
account for variation in loading. SERPINB12 and GAPDH were
analyzed in triplicate. Using the standard curve method, we
determined the level of expression of the examined genes using the
standard curves and CT values, and normalized them based on
GAPDH expression. For SERPINB12, the forward primer (59-GGC
TGG AAC AGA CTG AAA GC-39) and reverse primer (59-TGA
GGT TAA AGG TGC CTT CG-39) amplified a 129-bp product.
For GAPDH, the forward primer (59-CAG AAC ATC ATC CCA
GCG TC-39) and reverse primer (59-GGC AGG TCA GGT CAA
CAA CA-39) amplified a 133-bp product. The PCR conditions
were 94uC for 3 min, followed by 40 cycles at 95uC for 30 sec,
60uC for 30 sec, and 72uC for 30 sec using a melting curve
program (increasing the temperature from 55uC to 95uC at 0.5uC
per 10 sec) and continuous fluorescence measurement. ROX dye
(Invitrogen) was used as a negative control for the fluorescence
measurements. Sequence-specific products were identified by
generating a melting curve in which the Ct value represented
the cycle number at which a fluorescent signal was statistically
greater than background, and relative gene expression was
quantified using the 22DDCt method [50]. The relative quantifi-
cation of gene expression was normalized to the Ct value for the
control oviduct.
In Situ Hybridization Analysis
For hybridization probes, PCR products were generated from
cDNA using the primers described for RT-PCR analysis. The
products were extracted from the gel and cloned into the TOPO
Vector (Invitrogen, Carlsbad, CA). After verification of the
sequences, plasmids containing gene sequences were amplified
with T7- and SP6-specific primers (T7:59-TGT AAT ACG ACT
CAC TAT AGG G-39; SP6:59-CTA TTT AGG TGA CAC TAT
AGA AT-39) then digoxigenin (DIG)-labeled RNA probes were
transcribed using a DIG RNA labeling kit (Roche Applied
Science, Indianapolis, IN). Tissues were collected and fixed in
fresh 4% paraformaldehyde, embedded in paraffin and sectioned
at 5 mm on APES-treated slides. The sections were then
deparaffinized in xylene and rehydrated to diethylpyrocarbonate
(DEPC)-treated water through a graded series of alcohol. The
sections were treated with 1% Triton X-100 in PBS for 20 min,
washed two times in DEPC-treated PBS and then digested with
5 mg/ml Proteinase K (Sigma) in TE buffer (100 mM Tris-HCl,
50 mM EDTA, pH 8.0) at 37uC. After post-fixation in 4%
paraformaldehyde, sections were incubated twice for 5 min each
in DEPC-treated PBS and incubated in TEA buffer (0.1 M
triethanolamine) containing 0.25% (v/v) acetic anhydride. The
sections were incubated in a prehybridization mixture containing
50% formamide and 46 standard saline citrate (SSC) for at least
10 min at room temperature. After prehybridization, the sections
were incubated overnight at 42uC in a humidified chamber in a
hybridization mixture containing 40% formamide, 46SSC, 10%
dextran sulfate sodium salt, 10 mM DTT, 1 mg/ml yeast tRNA,
1 mg/ml salmon sperm DNA, 0.02% Ficoll, 0.02% polyvinylpyr-
rolidone, 0.2 mg/ml RNase-free bovine serum albumin and
denatured DIG-labeled cRNA probe. After hybridization, sections
were washed for 15 min in 26SSC at 37uC, 15 min in 16SSC at
37uC, 30 min in NTE buffer (10 mM Tris, 500 mM NaCl and
1 mM EDTA) at 37uC and 30 min in 0.16 SSC at 37uC. After
blocking with 2% normal sheep serum (Santa Cruz Biotechnology,
Inc., Santa Cruz, CA), the sections were incubated overnight with
sheep anti-DIG antibody conjugated to alkaline phosphatase
(Roche, Indianapolis, IN). The signal was visualized following
exposure to a solution containing 0.4 mM 5-bromo-4-chloro-3-
indolyl phosphate, 0.4 mM nitroblue tetrazolium, and 2 mM
levamisole (Sigma Chemical Co., St. Louis, MO).
Immunohistochemistry
Immunocytochemical localization of SERPINB12 protein was
performed as described previously using a rabbit polyclonal
antibody to SERPINB12 (catalog number: sc-85145; Santa Cruz
Biotechnology, Inc., Santa Cruz, CA) at a final dilution of 1:250
(0.4 mg/ml). Antigen retrieval was performed using the boiling
citrate method as described previously [51]. Negative controls
included substitution of the primary antibody with purified non-
immune rabbit IgG at the same final concentration.
Statistical Analyses
Data presented for quantitative PCR are expressed as mean 6
SEM unless otherwise stated. Differences in variances between
normal and cancerous ovaries were analyzed using the F test, and
differences between means were subjected to the Student’s t test.
Differences with a probability value of P,0.05 were considered
statistically significant. Excel (Microsoft, Redmond, WA) was used
for statistical analyses.
Acknowledgments
The authors thank members of the laboratory of Molecular Development
Engineering for their constant support and cooperation.
Author Contributions
Conceived and designed the experiments: GS. Performed the experiments:
GJ WL SMB. Analyzed the data: WL FWB GS. Contributed reagents/
materials/analysis tools: GS. Contributed to the writing of the manuscript:
GJ WL FWB GS.
References
1. Palmiter RD (1972) Regulation of protein synthesis in chick oviduct. II.
Modulation of polypeptide elongation and initiation rates by estrogen and
progesterone. J Biol Chem 247: 6770–6780.
2. Palmiter RD (1972) Regulation of protein synthesis in chick oviduct. I.
Independent regulation of ovalbumin, conalbumin, ovomucoid, and lysozyme
induction. J Biol Chem 247: 6450–6461.
3. Dougherty DC, Sanders MM (2005) Estrogen action: revitalization of the chick
oviduct model. Trends Endocrinol Metab 16: 414–419.
4. Sanders MM, Mcknight GS (1988) Positive and Negative Regulatory Elements
Control the Steroid-Responsive Ovalbumin Promoter. Biochemistry 27: 6550–
6557.
5. Lim W, Ahn SE, Jeong W, Kim JH, Kim J, et al. (2012) Tissue specific
expression and estrogen regulation of SERPINB3 in the chicken oviduct. Gen
Comp Endocrinol 175: 65–73.
6. Lim W, Jeong W, Kim J, Yoshimura Y, Bazer FW, et al. (2013) Expression and
regulation of beta-defensin 11 in the oviduct in response to estrogen and in
ovarian tumors of chickens. Mol Cell Endocrinol 366: 1–8.
7. Lim W, Jeong W, Kim JH, Lee JY, Kim J, et al. (2011) Differential expression of
alpha 2 macroglobulin in response to dietylstilbestrol and in ovarian carcinomas
in chickens. Reprod Biol Endocrinol 9: 137.
8. Lim W, Kim JH, Ahn SE, Jeong W, Kim J, et al. (2011) Avian SERPINB11
gene: characteristics, tissue-specific expression, and regulation of expression by
estrogen. Biol Reprod 85: 1260–1268.
SERPINB12 in the Avian Oviduct and Ovary
PLOS ONE | www.plosone.org 8 July 2014 | Volume 9 | Issue 7 | e99792
9. Bae SM, Lim W, Jeong W, Lee JY, Kim J, et al. (2014) Hormonal regulation of
beta-catenin during development of the avian oviduct and its expression in
epithelial cell-derived ovarian carcinogenesis. Mol Cell Endocrinol 382: 46–54.
10. Ahn SE, Jeong W, Kim JH, Lim W, Kim J, et al. (2012) ERBB receptor
feedback inhibitor 1: identification and regulation by estrogen in chickens. Gen
Comp Endocrinol 175: 194–205.
11. Jeong W, Kim J, Ahn SE, Lee SI, Bazer FW, et al. (2012) AHCYL1 is mediated
by estrogen-induced ERK1/2 MAPK cell signaling and microRNA regulation
to effect functional aspects of the avian oviduct. PLoS One 7: e49204.
12. Lee JY, Jeong W, Lim W, Kim J, Bazer FW, et al. (2012) Chicken pleiotrophin:
regulation of tissue specific expression by estrogen in the oviduct and distinct
expression pattern in the ovarian carcinomas. PLoS One 7: e34215.
13. Lim W, Jeong W, Kim J, Ka H, Bazer FW, et al. (2012) Differential expression
of secreted phosphoprotein 1 in response to estradiol-17beta and in ovarian
tumors in chickens. Biochem Biophys Res Commun 422: 494–500.
14. Jeong W, Lim W, Ahn SE, Lim CH, Lee JY, et al. (2013) Recrudescence
mechanisms and gene expression profile of the reproductive tracts from chickens
during the molting period. PLoS One 8: e76784.
15. Silverman GA, Whisstock JC, Askew DJ, Pak SC, Luke CJ, et al. (2004) Human
clade B serpins (ov-serpins) belong to a cohort of evolutionarily dispersed
intracellular proteinase inhibitor clades that protect cells from promiscuous
proteolysis. Cell Mol Life Sci 61: 301–325.
16. Hunt LT, Dayhoff MO (1980) A surprising new protein superfamily containing
ovalbumin, antithrombin-III, and alpha 1-proteinase inhibitor. Biochem
Biophys Res Commun 95: 864–871.
17. Silverman GA, Bird PI, Carrell RW, Church FC, Coughlin PB, et al. (2001) The
serpins are an expanding superfamily of structurally similar but functionally
diverse proteins. Evolution, mechanism of inhibition, novel functions, and a
revised nomenclature. J Biol Chem 276: 33293–33296.
18. Askew YS, Pak SC, Luke CJ, Askew DJ, Cataltepe S, et al. (2001) SERPINB12 is
a novel member of the human ov-serpin family that is widely expressed and
inhibits trypsin-like serine proteinases. J Biol Chem 276: 49320–49330.
19. Song G, Seo HW, Choi JW, Rengaraj D, Kim TM, et al. (2011) Discovery of
candidate genes and pathways regulating oviduct development in chickens. Biol
Reprod 85: 306–314.
20. Kaiserman D, Bird PI (2005) Analysis of vertebrate genomes suggests a new
model for clade B serpin evolution. BMC Genomics 6: 167.
21. Benarafa C, Remold-O’Donnell E (2005) The ovalbumin serpins revisited:
perspective from the chicken genome of clade B serpin evolution in vertebrates.
Proc Natl Acad Sci U S A 102: 11367–11372.
22. Berry WD (2003) The physiology of induced molting. Poult Sci 82: 971–980.
23. McKnight GS (1978) The induction of ovalbumin and conalbumin mRNA by
estrogen and progesterone in chick oviduct explant cultures. Cell 14: 403–413.
24. Crum CP, McKeon FD, Xian W (2012) The oviduct and ovarian cancer:
causality, clinical implications, and "targeted prevention". Clin Obstet Gynecol
55: 24–35.
25. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer
statistics. CA Cancer J Clin 61: 69–90.
26. Barua A, Bitterman P, Abramowicz JS, Dirks AL, Bahr JM, et al. (2009)
Histopathology of ovarian tumors in laying hens: a preclinical model of human
ovarian cancer. Int J Gynecol Cancer 19: 531–539.
27. Giles JR, Olson LM, Johnson PA (2006) Characterization of ovarian surface
epithelial cells from the hen: a unique model for ovarian cancer. Exp Biol Med
(Maywood) 231: 1718–1725.
28. Trevino LS, Giles JR, Wang W, Urick ME, Johnson PA (2010) Gene expression
profiling reveals differentially expressed genes in ovarian cancer of the hen:
support for oviductal origin? Horm Cancer 1: 177–186.
29. Ahn SE, Choi JW, Rengaraj D, Seo HW, Lim W, et al. (2010) Increased
expression of cysteine cathepsins in ovarian tissue from chickens with ovarian
cancer. Reprod Biol Endocrinol 8: 100.
30. Lim W, Kim JH, Ahn SE, Jeong W, Kim J, et al. (2012) Avian SERPINB11
gene: a marker for ovarian endometrioid cancer in chickens. Exp Biol Med
(Maywood) 237: 150–159.
31. Lim W, Kim HS, Jeong W, Ahn SE, Kim J, et al. (2012) SERPINB3 in the
chicken model of ovarian cancer: a prognostic factor for platinum resistance and
survival in patients with epithelial ovarian cancer. PLoS One 7: e49869.
32. Jeong W, Kim HS, Kim YB, Kim MA, Lim W, et al. (2012) Paradoxical
expression of AHCYL1 affecting ovarian carcinogenesis between chickens and
women. Exp Biol Med (Maywood) 237: 758–767.
33. Lee JY, Jeong W, Kim JH, Kim J, Bazer FW, et al. (2012) Distinct expression
pattern and post-transcriptional regulation of cell cycle genes in the glandular
epithelia of avian ovarian carcinomas. PLoS One 7: e51592.
34. Kato H, Torigoe T (1977) Radioimmunoassay for tumor antigen of human
cervical squamous cell carcinoma. Cancer 40: 1621–1628.
35. Chechlinska M, Kowalewska M, Brzoska-Wojtowicz E, Radziszewski J,
Ptaszynski K, et al. (2010) Squamous cell carcinoma antigen 1 and 2 expression
in cultured normal peripheral blood mononuclear cells and in vulvar squamous
cell carcinoma. Tumour Biol 31: 559–567.
36. Shiiba M, Nomura H, Shinozuka K, Saito K, Kouzu Y, et al. (2010) Down-
regulated expression of SERPIN genes located on chromosome 18q21 in oral
squamous cell carcinomas. Oncol Rep 24: 241–249.
37. Hsu KF, Huang SC, Shiau AL, Cheng YM, Shen MR, et al. (2007) Increased
expression level of squamous cell carcinoma antigen 2 and 1 ratio is associated
with poor prognosis in early-stage uterine cervical cancer. Int J Gynecol Cancer
17: 174–181.
38. Nakashima T, Yasumatsu R, Kuratomi Y, Masuda M, Kuwano T, et al. (2006)
Role of squamous cell carcinoma antigen 1 expression in the invasive potential of
head and neck squamous cell carcinoma. Head Neck 28: 24–30.
39. Gettins PG (2002) Serpin structure, mechanism, and function. Chem Rev 102:
4751–4804.
40. Suminami Y, Kishi F, Sekiguchi K, Kato H (1991) Squamous cell carcinoma
antigen is a new member of the serine protease inhibitors. Biochem Biophys Res
Commun 181: 51–58.
41. Luo JL, Tan W, Ricono JM, Korchynskyi O, Zhang M, et al. (2007) Nuclear
cytokine-activated IKKalpha controls prostate cancer metastasis by repressing
Maspin. Nature 446: 690–694.
42. Li HW, Leung SW, Chan CS, Yu MM, Wong YF (2007) Expression of maspin
in endometrioid adenocarcinoma of endometrium. Oncol Rep 17: 393–398.
43. Sood AK, Fletcher MS, Gruman LM, Coffin JE, Jabbari S, et al. (2002) The
paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res 8:
2924–2932.
44. Gronroos M, Maenpaa J, Kangas L, Erkkola R, Paul R, et al. (1987) Steroid
receptors and response of endometrial cancer to hormones in vitro. Ann Chir
Gynaecol Suppl 202: 76–79.
45. Baekelandt MM, Castiglione M (2008) Endometrial carcinoma: ESMO clinical
recommendations for diagnosis, treatment and follow-up. Ann Oncol 19 Suppl
2: ii19–20.
46. Creger CR, Scott JT (1977) Dietary Zinc as an Effective Resting Agent for
Laying Hen. Poultry Science 56: 1706–1706.
47. Berry WD, Brake J (1985) Comparison of Parameters Associated with Molt
Induced by Fasting, Zinc, and Low Dietary-Sodium in Caged Layers. Poultry
Science 64: 2027–2036.
48. Stewart MD, Johnson GA, Gray CA, Burghardt RC, Schuler LA, et al. (2000)
Prolactin receptor and uterine milk protein expression in the ovine endometrium
during the estrous cycle and pregnancy. Biol Reprod 62: 1779–1789.
49. Song G, Bazer FW, Spencer TE (2007) Pregnancy and interferon tau regulate
RSAD2 and IFIH1 expression in the ovine uterus. Reproduction 133: 285–295.
50. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:
402–408.
51. Song G, Spencer TE, Bazer FW (2006) Progesterone and interferon-tau regulate
cystatin C in the endometrium. Endocrinology 147: 3478–3483.
SERPINB12 in the Avian Oviduct and Ovary
PLOS ONE | www.plosone.org 9 July 2014 | Volume 9 | Issue 7 | e99792
